0001209191-22-014581.txt : 20220302 0001209191-22-014581.hdr.sgml : 20220302 20220302142941 ACCESSION NUMBER: 0001209191-22-014581 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hung David CENTRAL INDEX KEY: 0001310880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39351 FILM NUMBER: 22702748 MAIL ADDRESS: STREET 1: C/O AXOVANT SCIENCES, INC. STREET 2: 320 WEST 37TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvation Bio Inc. CENTRAL INDEX KEY: 0001811063 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850862255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 754-3517 MAIL ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Panacea Acquisition Corp DATE OF NAME CHANGE: 20200430 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-28 0 0001811063 Nuvation Bio Inc. NUVB 0001310880 Hung David C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036 1 1 1 0 President and CEO Class A Common Stock 58646800 D Stock Option (Right to Buy) 5.06 2022-02-28 4 A 0 2000000 0.00 A 2032-02-27 Class A Common Stock 2000000 2000000 D Includes 1,788 shares acquired on November 19, 2021 under the Issuer's 2021 Employee Stock Purchase Plan. Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. David Hung, by /s/ Kris Tsao Cachia, Attorney-in-Fact 2022-03-02